Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Debt (2020)

Historic Non-Current Debt for Caribou Biosciences (CRBU) over the last 1 years, with Q4 2020 value amounting to $924000.0.

  • Caribou Biosciences' Non-Current Debt changed N/A to $924000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $924000.0, marking a year-over-year change of. This contributed to the annual value of $924000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Caribou Biosciences reported Non-Current Debt of $924000.0 as of Q4 2020.
  • In the past 5 years, Caribou Biosciences' Non-Current Debt ranged from a high of $924000.0 in Q4 2020 and a low of $924000.0 during Q4 2020